Overestimated embryonic stem cell treatment
This year, an article was published in The Lancet (385; 509, 2015) that referred to the treatment of eye diseases such as age-associated macular degeneration and Stargardt disease (which can cause vision loss and even blindness) with retinal tissue produced from embryonic stem cells. The study had great media impact, in our opinion possibly exceeding its true therapeutic value. In this respect, two recent Letters to the Editor, also published in The Lancet (386;29-30,2015) have show their reservations regarding the findings obtained, both from a clinical point of view and owing to the low power of a phase 1 trial that only includes 18 patients.
La entrada Overestimated embryonic stem cell treatment. Eye diseases terapy aparece primero en Observatorio de Bioética, UCV.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.